| Identification | Back Directory | [Name]
(-)-5'-DMH-CBD | [CAS]
97452-63-6 | [Synonyms]
HU 219
CBD-DMH
-DMH-CBD
(-)-5'-DMH-CBD
5-(1,1-dimethylheptyl)cannabidiol
5-(1,1-Dimethylheptyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzendiol
5-(1,1-DIMETHYLHEPTYL)-2-[(1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL]-1,3-BENZENEDIOL
1,3-Benzenediol, 5-(1,1-dimethylheptyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]- | [Molecular Formula]
C25H38O2 | [MDL Number]
MFCD00870576 | [MOL File]
97452-63-6.mol | [Molecular Weight]
370.57 |
| Chemical Properties | Back Directory | [Boiling point ]
502.1±50.0 °C(Predicted) | [density ]
0.992±0.06 g/cm3(Predicted) | [storage temp. ]
Desiccate at -20°C | [solubility ]
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | [form ]
Oil to Gel | [pka]
9.56±0.45(Predicted) | [color ]
Light Yellow to Brown |
| Hazard Information | Back Directory | [Uses]
(-)-5'-DMH-CBD is a useful research chemical.(-)-5'-DMH-CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent. | [Biological Activity]
Anandamide membrane transport inhibitor (IC 50 = 14 μ M) that is relatively metabolically stable. Displays some affinity for CB 2 receptors but has only weak affinity for CB 1 receptors and has no activity at VR1 receptors or FAAH. Anticonvulsive in vivo following systemic administration. |
|
|